Refractory/Relapsed - Globe Thesis

Keyword [Refractory/Relapsed] Result: 1 - 20 \| Page: 1 of 2
1.	Clinical Research Of FATG Regimen To Treat Adult Patients With Refractory Acute Myeloid Leukemia
2.	Comparison Of Regimens In Treatment Of Refractory And Relapsed Acute Myeloid Leukemia
3.	Changes Of Intracellular Signal Pathway Of MTOR/S6 In T Cells Of Refractory/relapsed Aplastic Anemia
4.	MAH Regimen In Treatment Of Refractory And Relapsed Acute Myeloid Leukemia
5.	Clinical Study On MTA And MEA Regimen For Treatment Of Adult Refractory Or Relapsed Acute Leukemia
6.	Deoxycytidine Kinase Expression In Patients With Leukemia, Fludarabine, And Cytarabine Resistance-related Research
7.	Clinical Analysis Of HAA Induction Regimen For Newly Diagnosed And Refractory/Relapsed Acute Myeloid Leukemia
8.	IAG Regimen For Patients With Refractory And Relapsed Acute Leukemia
9.	The Expression Of Mitochondrial ATP Synthase Î² Subunit(ATPsyn-Î²) In Refractory/Relapsed Acute Myelogenous Leukemia And Its Effect On Drug Resistance And Prognosis
10.	The Efficacy And Safety Of The HAA Regimen In The Treatment Of Refractory/Relapsed Acute Myeloid Leukemia
11.	Clinical Outcome Of Treatment With A Combined Regimen Of Decitabine Followed By Low-dose Idarubicin And Cytarabine For Patients With High-risk Myelodysplastic Syndromes And AML Transformed From Myelodysplastic Syndromes(MDS/AML)
12.	A Primary Clinical Study Of Sorafenib Combined With Low Dose Cytarabine On FLT3~+ Relapsed And Refractory Acute Myeloid Leukemia
13.	The Analysis Of Clinical Efficacy Of Decitabine Combined With CAG Regimen In Treatment Of Elderly And Refractory/Relapsed Acute Myeloid Leukemia
14.	Preliminary Study On The Mechanism And Clinical Application Of Chidamide In Acute Myeloid Leukemia (AML)
15.	Analysis Of Clinical Features And Prognosis In Patients With Refractory/Relapsed Acute Myeloid Leukemia
16.	Clinical Outcome And Prognosis In Refractory/Relapsed Acute Leukemia With Haploid Aploidentical Non-in Vitro T Cell Peripheral Blood Stem Cell Transplantationacute
17.	Clinical Pathological Features Analysis Of Refractory/Relapsed Diffuse Large B Cell Lymphoma(DLBCL)
18.	Preliminary Clinical Study On Treatment Of Refractory/Relapsed Acute Leukemia With Tetrandrine
19.	Analysis Of Clinical Efficacy And Safety Of Three Different Treatments For Refractory/relapsed Acute Myeloid Leukemia
20.	Clinical Study On CAR-T Cells Combined With Dendritic Cells Pulsed With Eps8 Peptide For Refractory/Relapsed Acute Leukemia
<<First <Prev Next> Last>> Jump to